Last updated on June 2019

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Brief description of study

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Clinical Study Identifier: NCT03587805

Find a site near you

Start Over

LEO Pharma Investigational Site

North Bay, ON Canada
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.